|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/46 | (2006.01) |
| A61K 38/465 | (2013.01) | ||
| A61P 3/00 | (2006.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 19/10 | (2006.01) | ||
| A61P 19/10 | (2018.01) | ||
| A61P 19/08 | (2006.01) | ||
| A61P 19/08 | (2018.01) |
| (11) | Number of the document | 3672622 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18768948.4 |
| Date of filing the European patent application | 2018-08-22 | |
| (97) | Date of publication of the European application | 2020-07-01 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2018/056346 |
| Date | 2018-08-22 |
| (87) | Number | WO 2019/038685 |
| Date | 2019-02-28 |
| (30) | Number | Date | Country code |
| 201762549732 P | 2017-08-24 | US | |
| 17306720 | 2017-12-07 | EP |
| (72) |
SCHEIDT-PUGA, Ana Cristina , FR
|
| (73) |
Genzyme Corporation ,
450 Water Street, Cambridge, MA 02141,
US
|
| (54) | RECOMBINANT HUMAN ACID SPHINGOMYELINASE FOR USE IN TREATING ABNORMAL BONE CONDITIONS IN ACID SPHINGOMYELINASE DEFICIENCY PATIENTS |
| RECOMBINANT HUMAN ACID SPHINGOMYELINASE FOR USE IN TREATING ABNORMAL BONE CONDITIONS IN ACID SPHINGOMYELINASE DEFICIENCY PATIENTS |